Table 3 Results of univariate and multivariate risk factor analysis for percentage of IOP reduction by ripasudil at 12 weeks.
Univariate | Multivariate | |||
|---|---|---|---|---|
P value | 95% CI | P value | 95% CI | |
Sex (Male/Female) | 0.690 | − 9.109 to 6.069 | ||
Age (years) | 0.889 | − 0.330 to 0.287 | ||
Axial length (mm) | 0.029 | − 2.502 to − 0.138 | 0.528 | − 1.134 to 2.187 |
CCT (µm) | 0.492 | − 0.142 to 0.069 | ||
IOP-lowering medication number | 0.132 | − 9.166 to 1.228 | ||
Baseline IOP (mmHg) | < 0.001 | 0.562–2.041 | 0.005 | 0.336–1.810 |
PM | 0.001 | − 18.640 to − 4.691 | 0.028 | − 21.790 to − 1.297 |